Use of sildenafil and l-arginine in an experimental rat model for the prevention of neonatal necrotizing enterocolitis

Gabriela Araujo Moreira,André Ivan Bradley dos Santos Dias,Silvia Maria Suter Correia Cadena,Marília Locatelli Corrêa-Ferreira,Sergio Ossamu Ioshii,Camila Girardi Fachin
DOI: https://doi.org/10.1038/s41598-022-10323-8
IF: 4.6
2022-04-13
Scientific Reports
Abstract:Abstract Necrotizing enterocolitis (NEC) has a 45% mortality in neonatal intensive care units. This paper aimed to evaluate the isolated and combined effects of sildenafil and l -arginine in the prevention of necrotizing enterocolitis. Neonatal rats were fed formula milk and submitted to hypoxia under a 100% N2 atmosphere for 70 s. Then, animals were subjected to hypothermia (4 °C for 10 min), twice a day for 3 days. Forty neonatal rats were divided into five groups: negative control—not submitted to the protocol (n = 5), sildenafil group—NEC protocol (n = 9), l -arginine group—NEC protocol (n = 9), l -arginine and sildenafil group—NEC protocol (n = 9) and positive control—NEC protocol and intraperitoneal saline solution (n = 8). Jejunum and terminal ileus were removed for histopathologic and immunohistochemical Ki-67 analysis. Kruskal–Wallis test was used to analyze mortality, survival, body weight, intestinal injury score and Ki-67 proliferation index. All animals submitted to the protocol developed enterocolitis. Mortality rate was higher in group that received only l -arginine (p = 0.0293). The Ki-67 analysis showed a higher proliferative index in groups that received interventional drugs (p = 0.017). In conclusion, sildenafil and l -arginine were not effective to reduce intestinal injury.
multidisciplinary sciences
What problem does this paper attempt to address?